Edwards Lifesciences EW
NYSE EW
$103.34 +1.20 (+1.17%)
As of: Nov 9, 2026 · 9:57 AM EST

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2009 - 2026)

Updated

Edwards Lifesciences (EW) recorded Net Income towards Common Stockholders of $307.5 million in Q3 2026, up 5.6% from $291.1 million a year earlier and up 27.1% from the prior quarter.

Analysis

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

On a TTM basis, Edwards Lifesciences' Net Income towards Common Stockholders came in at $1.02 billion as of Sep 30, 2026, down 25.3% year-over-year; for FY2025, it came in at $1.07 billion, down 74.3% from FY2024.

  • Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
  • Across earlier years, Net Income towards Common Stockholders came in at $4.17 billion in FY2024 (+197.7%), $1.4 billion in FY2023 (-7.9%), $1.52 billion in FY2022 (+1.3%) and $1.5 billion in FY2021 (+82.5%).
  • Quarterly Net Income towards Common Stockholders has ranged from $91.2 million in Q4 2025 to $3.07 billion in Q3 2024 over the past five years.
  • On a year-over-year basis, Net Income towards Common Stockholders rose in four of the last eight quarters, with an average decline of 23.2%.
  • Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 697.8% in Q3 2024, against a decline of 90.5% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $241.9 million (Q2 2026), $380.7 million (Q1 2026) and $91.2 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 258.23 Bn 234.75 Bn 5.13 Bn 1.72 Bn
2 Abbott Laboratories 189.69 Bn 163.55 Bn 7.39 Bn 920.00 Mn
3 Danaher 161.73 Bn 141.39 Bn 3.84 Bn 1.24 Bn
4 Intuitive Surgical 159.20 Bn 139.49 Bn 2.08 Bn 522.80 Mn
5 Medtronic 130.49 Bn 95.74 Bn 6.34 Bn 1.47 Bn
6 Stryker 125.08 Bn 111.27 Bn 4.25 Bn 753.00 Mn
7 Boston Scientific 63.06 Bn 58.50 Bn 3.43 Bn 582.00 Mn
8 Edwards Lifesciences 59.30 Bn 42.51 Bn 1.35 Bn 307.50 Mn
9 Becton Dickinson 58.40 Bn 55.55 Bn 2.32 Bn 377.00 Mn
10 Agilent Technologies 49.44 Bn 42.33 Bn 1.04 Bn 362.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 307.50 Mn
Jun 30, 2026 241.90 Mn
Mar 31, 2026 380.70 Mn
Dec 31, 2025 91.20 Mn
Sep 30, 2025 291.10 Mn
Jun 30, 2025 333.20 Mn
Mar 31, 2025 358.00 Mn
Dec 31, 2024 385.60 Mn
Sep 30, 2024 3.07 Bn
Jun 30, 2024 366.30 Mn
Mar 31, 2024 351.90 Mn
Dec 31, 2023 369.90 Mn
Sep 30, 2023 384.90 Mn
Jun 30, 2023 307.10 Mn
Mar 31, 2023 340.50 Mn
Dec 31, 2022 398.40 Mn
Sep 30, 2022 343.50 Mn
Jun 30, 2022 406.40 Mn
Mar 31, 2022 373.60 Mn
Dec 31, 2021 335.30 Mn
API Access

Edwards Lifesciences Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EW&period=max&api_key=YOUR_API_KEY